Veradermics

MANENYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.379 B

$128.74 -5.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Veradermics (MANE) has a market capitalization of $5.38B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$70.0M

Loss-making

Shares outstanding

41,780,136

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#51Belite BioBLTE$5.76B
#52Ptc TherapeuticsPTCT$5.48B
#53VeradermicsMANE$5.38B
#54Cogent BiosciencesCOGT$5.14B
#55Travere TherapeuticsTVTX$4.70B

What if Veradermics were worth as much as…

Open the what-if tool →

Gold $28.2T

$675,844.47

Per share 5,250× higher

Bitcoin $1.53T

$36,568.77

Per share 284× higher

Apple $5.02T

$120,051.85

Per share 933× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Veradermics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.